全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

精神分裂症药物和物理治疗方法研究进展
Advances in Drug and Physical Therapy for Schizophrenia

DOI: 10.12677/ACM.2023.133498, PP. 3487-3491

Keywords: 精神分裂症,药物治疗,物理治疗,研究进展
Schizophrenia
, Drug Therapy, Physical Therapy, Advances

Full-Text   Cite this paper   Add to My Lib

Abstract:

精神分裂症(schizophrenia)目前被认为是一组病因未明的重性精神障碍,具有认知、思维、情感、行为等多方面精神活动的显著异常。具有较高病发率,严重影响患者身心健康及生活质量,对国家经济发展及社会稳定有极大影响。目前药物仍是临床治疗该病首选方式,但存在依存性差,且不良反应较多等缺点,易加剧患者身心负担,新型研究药物正在努力克服这些缺点。近些年物理治疗逐渐在我国发展为治疗新型手段,效果良好,且可有效避免药物不良反应,而且对急性期患者效果较显著。本文将对药物治疗和物理治疗新进展分别论述,旨在对临床工作提供一些有效指导。
Schizophrenia is currently considered to be a group of severe mental disorders with unknown eti-ology, with significant abnormalities in cognitive, thinking, emotional, behavioral and other mental activities. It has high incidence rate, seriously affects patients’ physical and mental health and quality of life, and greatly affects national economic development and social stability. At present, drugs are still the first choice for clinical treatment of this disease, but they have the disadvantages of poor dependence, and more adverse reactions, which easily aggravate the physical and mental burden of patients. New research drugs are trying to overcome these shortcomings. In recent years, physical therapy has gradually developed into a new treatment method in China, with good results. Besides, it can effectively avoid adverse drug reactions, and has a significant effect on patients in the acute phase. In this article, we discuss the new advances in drug therapy and physical therapy, respectively, in order to provide some effective guidance for clinical work.

References

[1]  Huang, Y.Q., et al. (2019) Prevalence of Mental Disorders in China: A Cross-Sectional Epidemiological Study. The Lancet Psychiatry, 6, 211-224.
https://doi.org/10.1016/S2215-0366(18)30511-X
[2]  Friedman, R.A. (2006) Vi-olence and Mental Illness—How Strong Is the Link? The New England Journal of Medicine, 355, 2064-2066.
https://doi.org/10.1056/NEJMp068229
[3]  郭超, 温煦, 郑晓瑛, 等. 中国精神残疾流行现状及其影响因素的研究进展[J]. 中国全科医学, 2016, 19(13): 1573-1577.
[4]  李连富, 文云云, 农玉娟. 难治性精神分裂症物理治疗的研究进展[J]. 当代医学, 2021, 27(32): 192-194.
[5]  孙来顺. 精神分裂症的药物治疗[J]. 医学信息, 2021, 34(21): 42-45.
[6]  彭国胜. 利培酮和奥氮平在难治性精神分裂症患者治疗中的应用效果对比分析[J]. 当代医学, 2018, 24(13): 106-107.
[7]  席华丽. 我院2009年-2013年抗精神病药应用分析[J]. 临床医药实践, 2016, 25(9): 686-689.
[8]  金枝, 罗继明, 王鹤秋. 帕利哌酮联合氯氮平治疗难治性精神分裂症的临床研究[J]. 现代实用医学, 2016, 28(8): 1034-1035.
[9]  陈东营. 氯氮平联合齐拉西酮治疗难治性精神分裂症89例疗效分析[J]. 中国实用医药, 2017, 12(14): 108-109.
https://doi.org/10.14163/j.cnki.11-5547/r.2017.14.058
[10]  He, B.M., et al. (2018) Neuroprotective Effect of Lurasidone via Antagonist Activities on Histamine in a Rat Model of Cranial Nerve Involvement. Molecular Medicine Reports, 17, 6002-6008.
https://doi.org/10.3892/mmr.2018.8595
[11]  朱静. 新型抗精神病药治疗精神分裂症的研究进展[J]. 国际精神学杂志, 2020, 47(6): 1096-1098.
[12]  刘雪滢, 孔庆梅, 司天梅, 郝伟. 新型抗精神病药卢美哌隆治疗精神分裂症的新进展[J]. 中华精神科杂志, 2021, 54(1): 57-61.
[13]  唐金蕾, 司淑萍, 翟金国, 赵靖平, 林烁. 新型抗精神病药SEP-363856 [J]. 中国新药杂志, 2021(8): 685-689.
[14]  中华医学会精神医学分会精神分裂症协作组, 中华医学会全科医学分会. 社区应用抗精神病药长效针剂治疗精神分裂症专家共识[J]. 中国全科医学, 2022, 25(29): 3587-3602.
[15]  Hasan, A., et al. (2017) World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia—A Short Version for Primary Care. International Journal of Psychiatry in Clinical Practice, 21, 82-90.
https://doi.org/10.1080/13651501.2017.1291839
[16]  Bhattacharya, A., Mrudula, K. and Sreepada, S. (2022) An Overview of Noninvasive Brain Stimulation: Basic Principles and Clinical Applications. Canadian Journal of Neurological Sciences, 49, 479-492.
https://doi.org/10.1017/cjn.2021.158
[17]  高学正, 张国富, 易峰, 李达, 刘敏黎. 重复经颅磁刺激治疗精神分裂症言语性幻听的研究进展[J]. 中国神经精神疾病杂志, 2019, 45(11): 693-696.
[18]  李斌. 重复经颅磁刺激对精神分裂症后抑郁的疗效观察[J]. 当代医学, 2021, 27(30): 169-170.
[19]  王俊杰, 周颖群, 甘鸿, 庞娇艳, 李惠, 王继军, 李春波. 重复经颅磁刺激治疗对精神分裂症患者阴性症状的疗效和安全性: 系统综述(英文) [J]. 上海精神医学, 2017, 29(2): 61-76.
[20]  占燕, 张红, 李晨虎, 占归来, 刘登堂, 骆艳丽. rTMS高频刺激精神分裂症前额叶背外侧疗效研究进展[J]. 精神医学杂志, 2021, 34(3): 279-283.
[21]  黄筑忆, 褚鹤龄, 蔡亦蕴. 脑深部电刺激治疗精神疾病的研究进展[J]. 中国神经精神疾病杂志, 2014, 40(7): 440-443.
[22]  王婧, 蒙莉莉, 徐再锋, 等. 无抽搐电休克治疗精神分裂症效果影响因素分析[J]. 中国神经精神疾病杂志, 2021, 47(6): 372-374.
[23]  Ahmadvand, A., Shahidi, S.B., Talari, H., et al. (2017) Morphology of the Corpus Callosum and Schizophrenia: A Case-Control Study in Kashan, Iran. Electron Physician, 9, 5478-5486.
https://doi.org/10.19082/5478
[24]  Ali Sana, A., et al. (2019) Electroconvulsive Therapy and Schizophrenia: A Systematic Review. Molecular Neuropsychiatry, 5, 75-83.
https://doi.org/10.1159/000497376
[25]  Flamarique, I., et al. (2012) Electroconvulsive Therapy and Clozapine in Adolescents with Schizophrenia Spectrum Disorders: Is It a Safe and Effective Combination? Journal of Clinical Psychopharmacology, 32, 756-766.
https://doi.org/10.1097/JCP.0b013e318270e2c7
[26]  孙婉娇, 黄永清. 改良电休克在精神分裂症临床治疗中的应用进展[J]. 医学综述, 2020, 26(4): 729-732+737.
[27]  Saba, G., Schurhoff, F. and Leboyer, M. (2006) Therapeutic and Neurophysiologic Aspects of Transcranial Magnetic Stimulation in Schizophrenia. Clinical Neurophysiology, 36, 185-194.
https://doi.org/10.1016/j.neucli.2006.08.008
[28]  唐晓楠. MECT对精神分裂症患者认知功能及短时记忆损伤的影响[J]. 中国医疗器械信息, 2020, 26(24): 66-67.
https://doi.org/10.15971/j.cnki.cmdi.2020.24.030

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133